Atsuhiro Sugidachi

2.7k citations

64 papers · 2.2k indexed · h-index 19

Cardiology and Cardiovascular Medicine top 1%
Surgery top 5%
Internal Medicine top 1%
Hematology top 5%
Pharmacology top 5%

Co-authors: Joseph A. Jakubowski Fumitoshi Asai Taketoshi Ogawa Y. Niitsu Kenneth J. Winters Oscar Ö. Braun David Erlinge Christoph Varenhorst
Topics: Antiplatelet Therapy and Cardiovascular Diseases (44 papers)Platelet Disorders and Treatments (20 papers)Venous Thromboembolism Diagnosis and Management (17 papers)
Cited by: Internal Medicine Cardiology and Cardiovascular Medicine Hematology
Journals: SHILAP Revista de lepidopterologíaJournal of the American College of Cardiology PLoS ONE
Partner nations: Japan United States Germany

In The Last Decade

Atsuhiro Sugidachi

64 papers receiving 2.1k citations

Peers

Countries citing papers authored by Atsuhiro Sugidachi

Since Specialization

Citations

This map shows the geographic impact of Atsuhiro Sugidachi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsuhiro Sugidachi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsuhiro Sugidachi more than expected).

Fields of papers citing papers by Atsuhiro Sugidachi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsuhiro Sugidachi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsuhiro Sugidachi. The network helps show where Atsuhiro Sugidachi may publish in the future.

Co-authorship network of co-authors of Atsuhiro Sugidachi

This figure shows the co-authorship network connecting the top 25 collaborators of Atsuhiro Sugidachi. A scholar is included among the top collaborators of Atsuhiro Sugidachi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsuhiro Sugidachi. Atsuhiro Sugidachi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A novel porcine model of thrombotic myocardial infarction with cardiac dysfunction sensitive to dual antiplatelet therapy 2018 ·European Journal of Pharmacology ·Makoto Mizuno,Yusuke Ito,Atsuhiro Sugidachi	2
2	A Novel Model of Intravital Platelet Imaging Using CD41-ZsGreen1 Transgenic Rats 2016 ·PLoS ONE ·Makoto Mizuno,(unknown),Kousaku Ohno,Joseph A. Jakubowski,Atsuhiro Sugidachi	6
3	Prasugrel reduces ischaemic infarct volume and ameliorates neurological deficits in a non-human primate model of middle cerebral artery thrombosis 2015 ·Thrombosis Research ·(unknown),Kousaku Ohno,Joseph A. Jakubowski,Makoto Mizuno,Atsuhiro Sugidachi	14
4	In vitro effects of recombinant activated factor VII on thrombin generation and coagulation following inhibition of platelet procoagulant activity by prasugrel 2013 ·Thrombosis Research ·Michael Mazzeffi,Fania Szlam,Joseph A. Jakubowski,Kenichi A. Tanaka,Atsuhiro Sugidachi,Jerrold H. Levy	7
5	Comparison of a new ELISA assay with the flow cytometric assay for platelet vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation in whole blood to assess P2Y12 inhibition 2011 ·Thrombosis and Haemostasis ·(unknown),(unknown),Atsuhiro Sugidachi,Shinji Yamaguchi,Paul Barragan,Chunmei Zhou,Joseph A. Jakubowski,Maxime Moulard	16
6	Evaluation of the INNOVANCE PFA P2Y test cartridge: Sensitivity to P2Y₁₂blockade and influence of anticoagulant 2011 ·Platelets ·(unknown),Joseph A. Jakubowski,Andreas R. Rechner,Atsuhiro Sugidachi,Paul Harrison	28
7	Effects of prasugrel, a novel P2Y12 inhibitor, in rat models of cerebral and peripheral artery occlusive diseases 2009 ·European Journal of Pharmacology ·Taketoshi Ogawa,Masami Hashimoto,Y. Niitsu,Joseph A. Jakubowski,(unknown),Ken‐ichi Otsuguro,Fumitoshi Asai,Atsuhiro Sugidachi	13
8	Patients With Poor Responsiveness to Thienopyridine Treatment or With Diabetes Have Lower Levels of Circulating Active Metabolite, but Their Platelets Respond Normally to Active Metabolite Added Ex Vivo 2008 ·Journal of the American College of Cardiology ·David Erlinge,Christoph Varenhorst,Oscar Ö. Braun,Stefan James,Kenneth J. Winters,Joseph A. Jakubowski,John T. Brandt,Atsuhiro Sugidachi,Agneta Siegbahn,Lars Wallentin	172
9	The reversible P2Y12 antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function 2008 ·Journal of Thrombosis and Haemostasis ·Natalia Dovlatova,Joseph A. Jakubowski,Atsuhiro Sugidachi,Stan Heptinstall	80
10	The active metabolite of prasugrel effectively blocks the platelet P2Y₁₂receptor and inhibits procoagulant and pro-inflammatory platelet responses 2008 ·Platelets ·Heather M. Judge,Robert Buckland,Atsuhiro Sugidachi,Joseph A. Jakubowski,Robert F. Storey	48
11	The influence of P2Y12 receptor deficiency on the platelet inhibitory activities of prasugrel in a mouse model: Evidence for specific inhibition of P2Y12 receptors by prasugrel 2007 ·Biochemical Pharmacology ·Masami Hashimoto,Atsuhiro Sugidachi,Takashi Isobe,Y. Niitsu,Taketoshi Ogawa,Joseph A. Jakubowski,Fumitoshi Asai	26
12	The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirin 2007 ·Journal of Thrombosis and Haemostasis ·Andrew L. Frelinger,J.A. Jakubowski,(unknown),M.R. BARNARD,Marsha L. Fox,Matthew D. Linden,Atsuhiro Sugidachi,Kenneth J. Winters,M.I. Furman,A D Michelson	5
13	Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species 2007 ·European Journal of Pharmacology ·Y. Niitsu,Atsuhiro Sugidachi,Taketoshi Ogawa,Joseph A. Jakubowski,Masami Hashimoto,Takashi Isobe,Ken‐ichi Otsuguro,Fumitoshi Asai	34
14	The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel’s active metabolite 2007 ·Journal of Thrombosis and Haemostasis ·Atsuhiro Sugidachi,Taketoshi Ogawa,Atsushi Kurihara,Katsunobu Hagihara,Joseph A. Jakubowski,Masami Hashimoto,Y. Niitsu,Fumitoshi Asai	165
15	Effects of R-102444, an orally active 5-HT2A receptor antagonist, in rat models of peripheral vascular disease 2004 ·Vascular Pharmacology ·Taketoshi Ogawa,Atsuhiro Sugidachi,Naoki Tanaka,Koichi Fujimoto,Fumitoshi Asai	7
16	[2-(.OMEGA.-Phenylalkyl)phenoxy]alkylamines. III. Synthesis and Selective Serotonin-2 Receptor Binding. (2). 2000 ·Chemical and Pharmaceutical Bulletin ·Naoki Tanaka,Ryota Goto,Rie Ito,(unknown),Atsuhiro Sugidachi,(unknown),Fumitoshi Asai,Koichi Fujimoto	9
17	Reduced platelet serotonin content in rabbits with dietary hypercholesterolemia 2000 ·Blood Coagulation & Fibrinolysis ·Taketoshi Ogawa,Atsuhiro Sugidachi,Fumitoshi Asai,(unknown)	4
18	Superiority of plasma 11-dehydro-TXB2 to TXB2 as an index of in vivo TX formation in rabbits after dosing of CS-518, A TX synthase inhibitor 1993 ·Thrombosis Research ·Wataru Takasaki,Akihiko Nakagawa,Fumitoshi Asai,Shigeru Ushiyama,Atsuhiro Sugidachi,Keiichi Matsuda,Takeshi Oshima,Yorihisa Tanaka	2
19	Age-associated Changes in Intracellular Ca²⁺Mobilization and Basal pH Level in Rat Platelets 1993 ·Platelets ·Atsuhiro Sugidachi,Fumitoshi Asai,Takeshi Oshima,Hiroyuki Koike	1
20	Platelet-Activating Factor in the Inflammatory Exudate in the Anaphylactic Phase of Allergic Inflammation in Rats 1987 ·International Archives of Allergy and Immunology ·Masako Watanabe,Kazuo Ohuchi,Atsuhiro Sugidachi,Noriyasu Hirasawa,(unknown),Susumu Tsurufuji	11

About Atsuhiro Sugidachi

Atsuhiro Sugidachi is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine, having authored 64 papers that have together received 2.2k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (44 papers), Platelet Disorders and Treatments (20 papers) and Venous Thromboembolism Diagnosis and Management (17 papers). The work is most often cited by research in Internal Medicine (515 citations), Cardiology and Cardiovascular Medicine (1.7k citations) and Hematology (354 citations). Atsuhiro Sugidachi has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Joseph A. Jakubowski, Fumitoshi Asai, Taketoshi Ogawa, Y. Niitsu, Kenneth J. Winters, Oscar Ö. Braun, David Erlinge, Christoph Varenhorst, Stefan James and Hiroyuki Koike. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact